Qualitest Pharmaceuticals Recalls Multiple Lots of Oral Contraceptives

The Food and Drug Administration Sept. 16 announced that Qualitest Pharmaceuticals has voluntarily recalled multiple lots of certain oral contraceptives.

The agency said a packaging error may result in the daily regimen for these products to be incorrect and could leave women without adequate contraception and at risk for unintended pregnancy. Specifically, select blisters were rotated 180 degrees within the package card, reversing the weekly tablet orientation and making the lot number and expiration date no longer visible, FDA said.

The recall is effective immediately and includes the following products:

• Cyclafem 7/7/7;
• Cyclafem 1/35;
• Emoquette;
• Gildess FE 1.5/30;
• Gildess FE ...